Target intelligence / Profile preview

Microbial cytoplasmic membrane and cell wall

Molecular classification
Cell envelope, Structural component, Lipid bilayer, Peptidoglycan, Lipopolysaccharide, Teichoic acid
01

Overview

The microbial cytoplasmic membrane and cell wall are essential structural layers that protect prokaryotic and fungal cells from environmental stress and osmotic lysis. The cell wall provides mechanical rigidity through complex polymers like peptidoglycan in bacteria or chitin and glucans in fungi, while the underlying cytoplasmic membrane serves as a selective barrier and a site for critical metabolic processes, including energy production and signal transduction [1, 2, 3, 7]. These structures are premier targets for antimicrobial therapy because they contain unique molecular features—such as D-amino acids and ergosterol—that are absent in human cells, enabling high selective toxicity [10, 11, 12]. Antibiotics like beta-lactams and glycopeptides disrupt cell wall synthesis, leading to rapid bactericidal effects, whereas membrane-targeting agents like polymyxins and lipopeptides compromise the lipid bilayer's integrity to cause lethal ion leakage [5, 6, 9]. Despite their historical success, the clinical utility of drugs hitting these targets is increasingly challenged by the evolution of resistance mechanisms, such as target site modification and enzymatic inactivation [1, 13, 15].

Other names
Bacterial cell wallBacterial cytoplasmic membraneProkaryotic cell envelopeMicrobial cell envelopePeptidoglycan layerPlasma membrane (microbial)
02

Mechanism of action

Inhibition of peptidoglycan synthesis (transpeptidation and transglycosylation), disruption of membrane integrity via pore formation or detergent-like action, inhibition of beta-glucan synthesis, and binding to membrane sterols to increase permeability.

03

Biological functions

Structural integrityOsmotic protectionSelective permeabilityCell divisionNutrient transportSignal transductionProtection from environmental stress
04

Disease associations

Bacterial infectionFungal infectionSepsisAntimicrobial resistance
05

Safety considerations

NephrotoxicityNeurotoxicityOtotoxicityAllergic reactionMicrobiome disruptionJarisch-Herxheimer reaction
06

Interacting drugs

Penicillin G

11 more in the full profile.

07

Biomarkers

Minimum Inhibitory Concentration (MIC)Procalcitonin (PCT)C-reactive protein (CRP)Gram stainCulture and sensitivity

Beyond the preview

Go deeper on Microbial cytoplasmic membrane and cell wall.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial cytoplasmic membrane and cell wall.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call